Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Role of High Mobility Group Box 1 as a Prognostic Biomarker in Patients Undergoing Valvular Heart Surgery

NCT02490644 is registered in ClinicalTrials.gov with Yonsei University as lead sponsor.

NCT NCT02490644
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02490644 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Role of High Mobility Group Box 1 as a Prognostic Biomarker in Patients Undergoing Valvular Heart Surgery
Lead sponsor
Yonsei University
Phase
Observational
Overall status
Completed
Start date
January 12, 2015
Completion date
September 29, 2017
Enrollment
250 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

valvular heart disease